Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

Cancer Drug Firm In 12-Year Kendall Square Lease

May 11, 2012 | Reprints | Unlock Link | Print

Cancer drug developer AVEO Pharmaceuticals has signed a 12-year lease for 126,000 square feet of laboratory and office space at 650 East Kendall Square in Cambridge.

The company will move its headquarters and primary research functions to the new location from 75 Sidney St. in Cambridge, according to BioMed Realty Trust, the REIT that owns the facility jointly with Prudential Real Estate Investors on behalf of institutional investors.

The building is a high-tech, six-story, 280,000-square-foot research facility with six levels of below-grade parking.

The lease arrangement was brokered by Boston commercial real estate firm Richards Barry Joyce & Partners. BioMed was represented by RBJ’s Steven Purpura, partner, and AVEO was represented by RBJ’s Jonathan Varholak, partner, and Eric Smith, senior vice president.

Commercial & Industrial